Aptevo Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | 106 | -106 | ||
EBITDA | -6,311 | -5,129 | -6,285 | -6,877 |
EBIT | -6,382 | -5,213 | -6,024 | -6,983 |
Net Income | -6,312 | -5,101 | -5,883 | -6,834 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -5,759 | -5,222 | -6,153 | -6,651 |
Cash | 8,714 | 7,753 | 8,066 | 10,250 |
Basic Shares | 285 | 285 | 285 | 343 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $3,114 | $12,292 |
Gross Profit | -567 | 2,213 | 12,292 | |
EBITDA | -24,602 | -28,311 | -27,740 | -20,256 |
EBIT | -28,878 | -28,641 | -21,400 | |
Net Income | -24,130 | -17,411 | 42,669 | -27,313 |
Net Change In Cash | 0 | 0 | 3,114 | 12,292 |
Free Cash Flow | -23,785 | -11,730 | -21,051 | -22,392 |
Cash | 8,714 | 16,904 | 22,635 | 45,044 |
Basic Shares | 285 | 278 | 115 | 106 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$8.94 |
2024-09-30 | -$0.48 |
2024-06-30 | -$1.67 |
2024-03-31 | -$9.95 |
